Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...

Eli Lilly LLY offers a diverse range of products that serve multiple therapeutic areas. While the company’s primary focus is ...

Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, ...

Pharmaceutical heavyweights Merck & Co. Inc. (NYSE: MRK) and Eli Lilly and Company (NYSE: LLY) are getting a lot of attention after outperforming the market by a mile in 2018. Both stocks have ...

Merck’s stock has declined by close to 10% since early February after the WHO declared the coronavirus a global health emergency, while Eli Lilly stock has fared much better and gained 15%. The ...

Eli Lilly (NYSE: LLY) and Merck (NYSE: MRK) are both among the largest biopharmaceutical businesses in the world, but their growth prospects aren't exactly the same. Nonetheless, the pair handily ...

2. Merck Is More Profitable . Eli Lilly’s operating margin of 24.5% over the last twelve-month period is slightly lower than 33.0% for Merck. This compares with 21.8% and 18.7% figures seen in ...

Issuing its Q2 earnings review for biopharma, Barclays has picked Eli Lilly (LLY) and Merck (MRK) as its top picks heading into the earnings season. Read more here.

Sales of Covid-19 drugs fueled year-over-year revenue growth for Merck MRK 0.13 % increase; green up pointing triangle & Co. Inc. and Eli Lilly LLY-2.71 % decrease; red down pointing triangle & Co ...

Pharmaceutical heavyweights Merck & Co. Inc. (MRK-0.26%) and Eli Lilly and Company (LLY 3.78%) are getting a lot of attention after outperforming the market by a mile in 2018. Both stocks have ...

Pharmaceutical heavyweights Merck & Co. Inc. (NYSE: MRK) and Eli Lilly and Company (NYSE: LLY) are getting a lot of attention after outperforming the market by a mile in 2018. Both stocks have ...